Table 1.
Rating Criteria with Nodule Size | Arterial Phase | Early Washout (<60 s) or Not |
Kupffer Phase (≥10 min) |
---|---|---|---|
LR-5 | |||
≥1 cm | Hyperenhancement (not rim, not peripheral discontinuous globular hyperenhancement) | No | Hypoechoic |
LR-M | |||
Nodule size not considered | Rim hyperenhancement or not rim, not peripheral discontinuous globular hyperenhancement | Yes | Hypoechoic |
LR-4 | |||
≥2 cm | No hyperenhancement | No | Hypoechoic |
≥1 cm | Not rim, not peripheral discontinuous globular hyperenhancement | No | Isoechoic or Hyperechoic |
<1 cm | Not rim, not peripheral discontinuous globular hyperenhancement | No | Hypoechoic |
LR-3 | |||
<2 cm | No hyperenhancement | No | Any |
≥2 cm | No hyperenhancement | No | Isoechoic or Hyperechoic |
<1 cm | Not rim, not peripheral discontinuous globular hyperenhancement | No | Isoechoic or Hyperechoic |
LR-2 | |||
<1 cm | Iso-enhancement | No | Isoechoic or Hyperechoic |
LR-1 | |||
Nodule size not considered | Definitely benign arterial phase pattern (cyst, hemangioma, focal fatty deposition/sparing, or other definitely benign finding) | No | N/A |